The latency-associated transcript (LAT) of herpes simplex virus 1 (HSV-1), CD8␣؉ dendritic cells (DCs), and programmed death 1 (PD-1) have all been implicated in the HSV-1 latency-reactivation cycle. It is not known, however, whether an interaction between LAT and CD8␣؉ A characteristic feature of infection with herpes simplex virus 1 (HSV-1) is the ability of the virus to establish latency in sensory neurons of an infected host (1-4). Individuals who have acquired a latent infection are subject to episodic recurrences and serve as permanent carriers who are intermittently infectious (5-7). The recurrences are caused by reactivation of the virus, which results in its transit back to the original site of infection (8, 9). More than 80 HSV-1 genes are expressed in neurons during lytic infection. This expression of HSV-1 genes is drastically curtailed during latency. Indeed, the latency-associated transcript (LAT) is the only gene product consistently detected in abundance during latency in infected mice, rabbits, and humans (1, 2, 4, 10, 11).Using LAT-expressing [LAT(ϩ)] and LAT-negative [LAT(Ϫ)] viruses, we recently demonstrated that the presence of LAT leads to the generation of dysfunctional T-cell responses in the trigeminal ganglia (TG) of latently infected mice (12). Both LAT expression and enhanced latency correlated with increased mRNA levels of CD8 and the inhibitory receptor programmed death 1 (PD-1) in the TG. These results suggested that TG that are latently infected with LAT(ϩ) virus contain both more CD8 ϩ T cells and more CD8ϩ T cells expressing the exhaustion marker, PD-1, than TG that are latently infected with LAT(Ϫ) virus. This was confirmed by flow cytometry analyses of expression of CD3, CD8, PD-1, HSV-1 gC, the gB 498 -505 -specific CD8 ϩ T-cell pentamer, interleukin-2 (IL-2), gamma interferon (IFN-␥), and tumor necrosis factor alpha (TNF-␣). The functional significance of PD-1 and its ligands in HSV-1 latency was indicated by the significantly lower levels of HSV-1 latency in mice that were deficient in PD-1 or PD-1 ligand 1 (PD-L1) than in wild-type (WT) mice. The levels of HSV-1 latency were unaffected in PD-L2-deficent mice. We have also shown that latency is enhanced by immunization of infected WT mice with FMS-like tyrosine kinase 3 ligand (Flt3L) DNA, which increases the number of dendritic cells (DCs) (13,